Elizabeth Barrett - 18 Jun 2025 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/Earl Douglas, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
18 Jun 2025
Net transactions value
$0
Form type
4
Filing time
23 Jun 2025, 21:03:34 UTC
Previous filing
13 Jun 2025
Next filing
30 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Barrett Elizabeth A. Director 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO /s/Earl Douglas, Attorney-in-Fact 20 Jun 2025 0001764157

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Restricted Stock Unit Award $0 +95,400 $0.000000 95,400 18 Jun 2025 Common Stock 95,400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Barrett has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company.

Remarks:

Exhibits: Power of Attorney